Grade: Research grade

Factory Location: Hangzhou,China.

Main Sales Markets: North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East,Africa

Monthly Production Capacity: hundreds of grams

Contract Manufacturing: CRO

Packaging Information: 1g, 5g, 10g, 20g, 50g,100g

Delivery Lead Time: In stock or 2-3weeks

Sample Provided: yes

Payment Terms: bank transit

Pramlintide is a relatively new adjunct treatment for diabetes (both type 1 and 2), developed by Amylin Pharmaceuticals. It is derived from amylin, a hormone that is released into the bloodstream, in a similar pattern as insulin, after a meal. Like insulin, amylin is deficient in individuals with diabetes.